3D graphic showing human hematopoietic stem cells originating from bone marrow
3D graphic showing human hematopoietic stem cells originating from bone marrow
Logo

Genetic engineering and manufacturing of hematopoietic stem cells

The CliniMACS Prodigy® Hematopoietic Stem Cell Transduction – Large Scale (HSCT-LS) allows automated transduction of patient-derived CD34+ cells for large-scale clinical manufacturing of gene-engineered hematopoietic stem cells (HSCs). All steps, from CD34+ enrichment to engineering and harvest, run on the CliniMACS Prodigy Instrument within a closed system, providing a controlled, sterile, and GMP-compliant cell manufacturing workflow that adapts and scales with your starting material and production needs.

Standardizing HSC gene therapy: from manual processes to automated manufacturing in a single, closed platform

Genetic engineering of CD34+ HSCs offers a promising therapeutic approach for inherited disorders, such as sickle cell disease, ß-thalassemia, or primary immunodeficiencies1–3. Yet donor‑to‑donor variability in both cell number and cell functionality, as well as inconsistencies introduced by manual, open processing steps, remain major barriers to CD34⁺ manufacturing, reducing transduction efficiency and final product yield4,5.

The CliniMACS Prodigy Platform overcomes these challenges by integrating all HSC manufacturing steps within a single, closed system:

  • Automated manufacturing in a closed system: Easy conversion of manual protocols into standardized processes executed within sterile, single-use tubing sets, minimizing donor- and operator-dependent variability and improving reproducibility and final yield.
  • Scalable HSC engineering: An enlarged cultivation chamber supports a wider, more flexible range of cultivation volumes and cell densities, providing robust processing for both limited pediatric material and adult samples.
  • Streamlined process monitoring: Integrated sampling pouches on the CliniMACS Tubing Sets enable seamless quality control at any time throughout the cell manufacturing process, strengthening traceability and product quality.

Large-scale HSC engineering: from patient material to targeted cell therapies in one workflow

The CliniMACS Prodigy Platform offers an end-to-end solution for clinical cell manufacturing of gene-engineered HSCs, integrating two applications within a closed, automated system: HSC enrichment and large-scale HSC transduction. Each process runs in dedicated sterile, single-use tubing sets. Control samples can be collected at any point for flow cytometry–based quality control analysis.

Leukapheresis product

Built for versatility, the platform processes fresh or frozen leukapheresis products.

Graphic showing leukapheresis products

Leukapheresis product

Built for versatility, the platform processes fresh or frozen leukapheresis products.

HSC enrichment

Automated magnetic cell separation yields a highly pure starting CD34+ cell population.

See more

Graphic showing HSC enrichment as part of the large-scale HSC engineering process

HSC enrichment

Automated magnetic cell separation yields a highly pure starting CD34+ cell population.

See more

Large-scale HSC engineering

Large-scale, automated cultivation and transduction provide the flexibility to adjust processing volumes as needed while maximizing overall product yield.

See more

Graphic showing the process of large-scale HSC engineering, including  automated cultivation and transduction

Large-scale HSC engineering

Large-scale, automated cultivation and transduction provide the flexibility to adjust processing volumes as needed while maximizing overall product yield.

See more

Final cell product

The result: high-quality, gene-engineered HSCs formulated to meet a broad range of dose and volume specifications.

Graphic showing the the final product of gene-engineered HSCs

Final cell product

The result: high-quality, gene-engineered HSCs formulated to meet a broad range of dose and volume specifications.

Quality control testing

Flexible sample collection throughout HSC manufacturing, supporting rigorous process monitoring through standardized flow cytometry assays.

See more

Graphic showing an antibody binding a cell next to a DNA strand

Quality control testing

Flexible sample collection throughout HSC manufacturing, supporting rigorous process monitoring through standardized flow cytometry assays.

See more

Overview of the CliniMACS Prodigy large-scale HSC Engineering workflow

Leukapheresis product

Built for versatility, the platform processes fresh or frozen leukapheresis products.

Graphic showing leukapheresis products

Leukapheresis product

Built for versatility, the platform processes fresh or frozen leukapheresis products.

HSC enrichment

Automated magnetic cell separation yields a highly pure starting CD34+ cell population.

See more

Graphic showing HSC enrichment as part of the large-scale HSC engineering process

HSC enrichment

Automated magnetic cell separation yields a highly pure starting CD34+ cell population.

See more

Large-scale HSC engineering

Large-scale, automated cultivation and transduction provide the flexibility to adjust processing volumes as needed while maximizing overall product yield.

See more

Graphic showing the process of large-scale HSC engineering, including  automated cultivation and transduction

Large-scale HSC engineering

Large-scale, automated cultivation and transduction provide the flexibility to adjust processing volumes as needed while maximizing overall product yield.

See more

Final cell product

The result: high-quality, gene-engineered HSCs formulated to meet a broad range of dose and volume specifications.

Graphic showing the the final product of gene-engineered HSCs

Final cell product

The result: high-quality, gene-engineered HSCs formulated to meet a broad range of dose and volume specifications.

Quality control testing

Flexible sample collection throughout HSC manufacturing, supporting rigorous process monitoring through standardized flow cytometry assays.

See more

Graphic showing an antibody binding a cell next to a DNA strand

Quality control testing

Flexible sample collection throughout HSC manufacturing, supporting rigorous process monitoring through standardized flow cytometry assays.

See more

Get personalized support to optimize your gene-engineered HSC manufacturing workflows

1. Establishing your starting material: HSC enrichment

Graphic showing HSC enrichment as part of the large-scale HSC engineering process

The workflow begins with the CliniMACS Prodigy HSC Enrichment System and the sterile tubing set TS 320. Leveraging MACS® Technology for magnetic cell separation, the system automates CD34+ cell enrichment and seamlessly generates a high-quality starting cell population for downstream genetic modification.

  • Robust CD34+ cell enrichment: Reproducible isolation of highly pure CD34⁺ HSCs with high viability.
  • Flexible starting material: Compatible with fresh or cryopreserved6 mobilized leukapheresis products.

Graph showing the performance of the CliniMACS Prodigy HSC Enrichment System, with T and B cell depletion, and HSC viability, purity, and yield.
Performance metrics of CD34+ cell enrichment with the CliniMACS Prodigy.

Robust HSC enrichment

The automated CliniMACS Prodigy HSC Enrichment System enables CD34+ cell enrichment with high purity and viability.

2. Large-scale HSC engineering: flexible volumes for scalable manufacturing

Graphic showing the process of large-scale HSC engineering, including  automated cultivation and transduction

The enriched CD34+ cells are transferred into a cell bag and connected to the tubing set TS 620 for automated cell engineering using the CliniMACS Prodigy HSCT-LS System. Before proceeding with transduction, CD34+ cells are cultured in HSC-Brew GMP Medium* supplemented with MACS GMP Recombinant Human Cytokines* (SCF, TPO, and Flt3-Ligand). Gene-engineered HSCs are harvested in a buffer of choice, yielding a final product suitable for subsequent steps such as cryopreservation or functional assays.

  • Flexible volume processing suited for pediatric and adult therapeutic applications: HSCT-LS supports both small-scale, highly concentrated cell products for pediatric applications and high-volume cultivation and harvest for adult samples or large-scale manufacturing.

*All MACS GMP Products are manufactured and tested under a quality management system (ISO 13485) and are compliant with relevant GMP guidelines. Explore MACS GMP Quality for details.

Two employees wearing clean room attire sharing data.
Miltenyi Bioindustry – CDMO Service

Having trouble transducing your HSCs? We can help.

Boost your HSC transduction success with our baboon envelope pseudotyped (BaEV) lentiviral vector (LVV) platform. Designed to efficiently transduce hard-to-modify cells like HSCs, our BaEV LVVs outperform traditional vectors such as VSV-G and are fully supported by preclinical and GMP manufacturing services, helping you move toward the clinic with confidence.

Explore our service

3. Quality control by standardized flow cytometry workflows

Two MACSQuant Analyzer flow cytometer in a clean room used for cell analysis during cell and gene therapy manufacturing on the CliniMACS Prodigy Platform in the background

To enable safe and consistent cell manufacturing, implementation of robust in-process control and release testing (IPC/RT) is crucial.

Samples collected within the manufacturing process, e.g., on the CliniMACS Prodigy, are analyzed on our standardized flow cytometry platform. Our comprehensive workflow solution comprises:

  • harmonized, automated MACSQuant® Flow Cytometers
  • automated data acquisition and analysis (Express Modes)
  • 21 CFR Part 11 software module supporting GMP compliance
  • broad portfolio of REAfinity® Recombinant Antibodies with superior specificity and reproducibility
  • ready-to-use HSC staining cocktails and functional assays

Bar graphs showing the total number of colonies per plate (A) and the number of colony types per plate (B) for 3 donors, using the StemMACS HSC-CFU Assay Kit to evaluate the HSC differentiation potential.
Flow cytometry–based colony-forming unit (CFU) quantification for evaluation of HSC proliferation (A) and differentiation potential (B) with the StemMACS HSC CFU Assay.

Standardized HSC analysis by flow cytometry

The StemMACS™ HSC CFU Assay provides a robust, user-independent quality control evaluation of HSC proliferation and multilineage differentiation potential, replacing traditional microscope-based scoring with standardized, marker-based flow cytometry readouts. Combined with automated analysis using the Stem Cell Analysis Cocktail Kits and Express Modes, it provides a standardized and reproducible method for comprehensive HSC characterization throughout manufacturing.

Get personalized support for your manufacturing workflows of gene-engineered HSCs

Unless otherwise specifically indicated, Miltenyi Biotec products and services are for research use only and not for therapeutic or diagnostic use. For complete regulatory notes, please click here.

You have previously chosen International as your location.
What do you want to do?